Intelligent Bio Solutions INBS Ratios (2019-2025)

NASDAQ INBS
$2.65 -0.02 (-0.75%)
At close: Aug 20, 2026 · 4:00 PM EDT
Ratios Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Profitability
Gross Margin (Quarter)
68.42%7.23%11.19%29.18%26.08%21.67%39.76%36.73%46.84%
EBT Margin (Quarter)
-1,942.94%-703.23%-9,164.97%-201.10%-1,948.26%-698.25%-682.51%-2,168.83%-2,881.88%-1,389.76%-2,760.58%-413.45%-364.63%-453.27%-402.48%-498.44%-460.15%
EBIT Margin (Quarter)
-1,196.16%-324.10%-9,158.69%-201.67%-1,949.84%-697.57%-174.89%-350.62%-597.45%-1,431.63%-609.86%-317.35%-260.63%-358.55%-312.43%-372.76%-351.28%
EBITDA Margin (Quarter)
-1,196.16%-324.10%-9,158.69%-201.67%-1,949.84%-697.57%-174.89%-350.62%-597.45%-1,431.63%-609.86%-317.35%-260.63%-358.55%-312.43%-372.76%-351.28%
Operating Margin (Quarter)
-1,196.16%-324.10%-9,158.69%-201.67%-1,949.84%-697.57%-174.89%-350.62%-597.45%-1,431.63%-609.86%-317.35%-260.63%-358.55%-312.43%-372.76%-351.28%
Net Margin (Quarter)
-1,942.94%-1,394.49%-19,050.78%1,691.86%-1,948.26%-698.25%-682.51%-2,168.83%-2,881.88%-1,389.76%-2,760.58%-413.45%-364.63%-453.27%-402.48%-498.44%-460.15%
FCF Margin (Quarter)
-4,830.25%-274.51%-17,962.77%-312.24%-801.82%-151.80%-144.33%-544.98%-667.50%-551.01%-131.86%-164.78%-375.51%-296.68%-273.67%-382.68%-380.01%
Efficiency
Inventory Average (Quarter)
0.70M0.86M0.97M0.95M0.91M0.83M0.76M0.72M0.69M0.66M
Assets Average (Quarter)
18.71M19.66M20.48M17.17M14.80M13.36M11.26M14.10M14.36M10.51M9.53M8.76M12.93M15.41M12.75M10.20M9.13M8.92M
Invested Capital (Quarter)
0.43M0.04M0.01M0.07M0.01M2.84M1.02M0.52M0.49M
Asset Utilization Ratio (Quarter)
0.020.040.050.060.150.170.150.160.150.220.280.220.260.300.33
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-7.79-1.01-0.63-0.20-0.54-0.18-0.34-0.19-0.26-0.86-0.28-3.30-2.50-3.73-0.27-3.25-2.88-3.16
Debt Ratio (Quarter)
0.020.000.000.000.000.230.100.030.040.040.040.030.01
Times Interest Earned (Quarter)
-7.79-1.01-0.63-0.20-0.54-0.18-0.34-0.19-0.26-0.86-0.28-3.30-2.50-3.73-0.27-3.25-2.88-3.16
Valuation
Enterprise Value (Quarter)
-19.92M-14.32M-12.62M-12.66M-11.25M-10.83M-8.32M-5.83M-3.00M-2.38M-0.11M-0.12M-0.13M-0.14M-0.15M-4.15M-2.40M-2.98M-1.20M
Return Ratios
Return on Sales (Quarter)
-0.19%-0.14%-1.91%0.17%-0.19%-0.07%-0.07%-0.22%-0.29%-0.14%-0.28%-0.04%-0.04%-0.05%-0.04%-0.05%-0.05%
Return on Capital Employed (Quarter)
-30.49%-34.89%-35.97%-67.61%-68.51%-95.91%-91.20%-72.99%-110.70%-272.15%-518.47%-384.39%-140.78%-103.26%-148.19%-185.37%-226.74%
Return on Invested Capital (Quarter)
-0.02%-0.04%-0.01%
Return on Assets (Quarter)
-0.01%0.00%0.00%0.00%0.00%-0.01%-0.02%-0.02%-0.02%-0.03%-0.03%-0.03%-0.02%-0.01%-0.02%-0.02%-0.03%-0.01%